πŸ‡ΊπŸ‡Έ FDA
Patent

US 8193312

Bone morphogenic protein binding peptide

granted A61KA61K35/28A61K38/12

Quick answer

US patent 8193312 (Bone morphogenic protein binding peptide) held by The Regents of the University of California expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/28, A61K38/12, A61K38/1841, A61K38/1875